# A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in Belgium

> **NCT00309205** · PHASE1,PHASE2 · COMPLETED · sponsor: **International Partnership for Microbicides, Inc.** · enrollment: 36 (—)

## Conditions studied

- HIV Infections
- HIV-1

## Interventions

- **DRUG:** dapivirine (TMC120) vaginal gel

## Key facts

- **NCT ID:** NCT00309205
- **Lead sponsor:** International Partnership for Microbicides, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 36 (—)
- **Last updated:** 2009-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00309205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00309205, "A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in Belgium". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00309205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*